Floatz logo

Endostar

Unspecified Adult Solid Tumor, Protocol Specific

University of Wisconsin, Madisonprotein_peptidePhase 1Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Unspecified Adult Solid Tumor, Protocol Specific cohort.

Asset / SponsorPhaseRating
NEPENTHE
M.D. Anderson Cancer Center
Phase 4BBB
Amifostine
M.D. Anderson Cancer Center
Phase 4BBB
DEXAMETHASONE
Alliance for Clinical Trials in Oncology
Phase 3BBB
FLUTICASONE
Barbara Ann Karmanos Cancer Institute
Phase 2BBB
ETOPOSIDE
University of California, Davis
Phase 2/3BBB

View all 50 →

Same molecule, other indications

Endostar is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
70 / 100
View asset →
colorectal neoplasmDormant
B
Indicative ·
63 / 100
View asset →
Leptomeningeal MetastasisDormant
B
Indicative ·
62 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →